Compare Immunovant Inc. Common Stock (IMVT) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Global X Lithium & Battery Tech ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Global X Lithium & Battery Tech ETF trades at $68.96 (market cap $1.49B). The key difference: Immunovant Inc. Common Stock is far larger — about 4.4× Global X Lithium & Battery Tech ETF's market cap, and Global X Lithium & Battery Tech ETF is more actively traded (67,221 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Global X Lithium & Battery Tech ETF for 56 Days on average.
| IMVT | LIT | |
|---|---|---|
Market Cap | $6.62B | $1.49B |
Volume | 1,131,364 | 67,221 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $44.96 | $91.62 |
52-Week Low | $17.03 | $53.92 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $5.72B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LIT trades at $69.51, down 2.2% today amid mixed technical signals with a bullish overall rating but bearish moving averages and oscillators. The ETF's recent performance reflects volatility in lithium markets, with short interest dropping 53.1% in September. Key technical levels show support at $70 and resistance at $72. Recent news highlights ongoing EV sector growth with China targeting 30% NEV fleet by 2030, providing long-term tailwinds.
LIT offers exposure to the expanding battery technology sector with catalysts from EV adoption and energy storage demand. However, risks include lithium price volatility and Chinese export controls. The ETF's momentum is supported by semiconductor and AI-driven battery demand, though current technical indicators suggest near-term consolidation may precede further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
